The global stretch marks treatment market size was valued at USD 3.13 Billion in 2024. Looking forward, the analyst estimates the market to reach USD 4.95 Billion by 2033, exhibiting a CAGR of 5.2% from 2025-2033.Key stretch marks treatment market trends in North America include the high demand for advanced skincare solutions due to increased awareness, rising disposable income, and the prevalence of post-pregnancy and weight-related skin concerns. As per the WHO article released in August 2024, roughly 1 in 8 people worldwide experienced obesity in 2022.
Stretch marks are scars or irregular lines that develop when the skin stretches or shrinks suddenly. They are widely caused by unexpected changes in the body that cause the collagen and elastin to rupture and as the skin heals naturally, stretch marks occur. They are also caused by Cushing syndrome, abnormal collagen formation and Ehlers-danlos syndrome.
Stretch marks are common in pregnant women and individuals with rapid changes in muscle size due to significant weight gain or weight loss. Some of the commonly used stretch mark treatment solutions include lotions, creams, pulse-dye lasers, fractional lasers, oil and serums. They aid in reducing the visibility of stretch marks by rebuilding collagen for tightening the skin and treating open pores and fine lines.
Additionally, various product innovations, such as the launch of chemical peels, platelet-rich plasma (PRP), micro-needling, non-invasive microdermabrasion and laser-based treatment procedures, are providing a thrust to the market growth. These procedures aid in the breakdown of old collagen and promote the development of new skin tissues. Other factors, including the convenient availability of over-the-counter stretch marks ointments, along with the increasing consciousness among the masses regarding their physical appearance, are anticipated to drive the market toward growth.
Stretch marks are scars or irregular lines that develop when the skin stretches or shrinks suddenly. They are widely caused by unexpected changes in the body that cause the collagen and elastin to rupture and as the skin heals naturally, stretch marks occur. They are also caused by Cushing syndrome, abnormal collagen formation and Ehlers-danlos syndrome.
Stretch marks are common in pregnant women and individuals with rapid changes in muscle size due to significant weight gain or weight loss. Some of the commonly used stretch mark treatment solutions include lotions, creams, pulse-dye lasers, fractional lasers, oil and serums. They aid in reducing the visibility of stretch marks by rebuilding collagen for tightening the skin and treating open pores and fine lines.
Stretch Marks Treatment Market Trends:
The increasing incidence of obesity among the masses is one of the key factors driving the market growth. With the changing dietary patterns and the rising adoption of sedentary lifestyles, individuals are widely suffering from excessive weight gain, which is leading to the development of stretch marks. Moreover, the increasing product demand among pregnant women is favoring the market growth. Stretch marks lotions, oils and serums are fortified with essential oils and nutrients that aid in minimizing the visibility of stretched and broken skin and promote healing.Additionally, various product innovations, such as the launch of chemical peels, platelet-rich plasma (PRP), micro-needling, non-invasive microdermabrasion and laser-based treatment procedures, are providing a thrust to the market growth. These procedures aid in the breakdown of old collagen and promote the development of new skin tissues. Other factors, including the convenient availability of over-the-counter stretch marks ointments, along with the increasing consciousness among the masses regarding their physical appearance, are anticipated to drive the market toward growth.
Key Market Segmentation:
This report provides an analysis of the key trends in each segment of the global stretch marks treatment market, along with forecasts at the global, regional, and country levels from 2025-2033. The market has been categorized based on treatment, distribution channel, and end user.Breakup by Treatment:
- Topical Products
- Creams
- Oils and Serum
- Lotions
- Lasers
- Fractional Lasers
- Pulse-Dye Lasers
- Others
- Microdermabrasion
- Others
Breakup by Distribution Channel:
- Institutional
- Retail
- Supermarkets and Hypermarkets
- Specialist Retailers
- Medical Retailers
- Online Stores
- Others
Breakup by End User:
- Hospitals and Clinics
- Home Use
- Specialty Dermatology Centers
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Alliance Pharma PLC, basq NYC, Bayer AG, Candela Corporation, Clarins, Dermaclara, E.T. Browne Drug Co. Inc., Helix Biomedix Inc., HRA Pharma (Perrigo Company plc), Laboratoires Expanscience, Union-Swiss (Pty) Ltd and Weleda.Key Questions Answered in This Report:
- What is a stretch mark?
- How big is the stretch marks treatment market?
- What is the expected growth rate of the global stretch marks treatment market during 2025-2033?
- What are the key factors driving the global stretch marks treatment market?
- What is the leading segment of the global stretch marks treatment market based on treatment?
- What is the leading segment of the global stretch marks treatment market based on end user?
- What are the key regions in the global stretch marks treatment market?
- Who are the key players/companies in the global stretch marks treatment market?
Table of Contents
1 Preface3 Executive Summary11 Value Chain Analysis13 Price Analysis
2 Scope and Methodology
4 Introduction
5 Global Stretch Marks Treatment Market
6 Market Breakup by Treatment
7 Market Breakup by Distribution Channel
8 Market Breakup by End User
9 Market Breakup by Region
10 SWOT Analysis
12 Porters Five Forces Analysis
14 Competitive Landscape
List of Figures
List of Tables
Companies Mentioned
- Alliance Pharma PLC
- basq NYC
- Bayer AG
- Candela Corporation
- Clarins
- Dermaclara
- E.T. Browne Drug Co. Inc.
- Helix Biomedix Inc.
- HRA Pharma (Perrigo Company plc)
- Laboratoires Expanscience
- Union-Swiss (Pty) Ltd
- Weleda
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 139 |
| Published | April 2025 |
| Forecast Period | 2024 - 2033 |
| Estimated Market Value ( USD | $ 3.13 Billion |
| Forecasted Market Value ( USD | $ 4.95 Billion |
| Compound Annual Growth Rate | 5.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 12 |
